Publication|Articles|February 2, 2024

Pharmaceutical Technology

  • Pharmaceutical Technology, February 2024
  • Volume 48
  • Issue 2
  • Pages: 10

ROSS Dual-Shaft Mixers

Designed for processing high viscosity dispersions and suspensions, the ROSS line of Dual-Shaft Mixers are versatile systems utilized in the chemical, pharmaceutical, food, cosmetic, adhesive, coating, composite, and other industries.

Designed for processing high viscosity dispersions and suspensions, the ROSS line of Dual-Shaft Mixers are versatile systems utilized in the chemical, pharmaceutical, food, cosmetic, adhesive, coating, composite, and other industries. The purpose-built ROSS FDA-1500 (pictured) has a maximum working capacity of 1500 gallons and features a dish-bottom stainless-steel mix vessel with a 50-psig dimpled heating/cooling jacket. The dome-style cover includes multiple charging ports as well as a hinged manway providing access for major ingredient additions and cleaning. The FDA-1500 is capable of operating under vacuum up to 29.5”Hg.

The mixer’s independently-driven agitators—a 40 HP Two-Wing Anchor and a 150 HP High Speed Disperser—are supported from a heavy-duty agitator bridge. Agitator shafts are sealed via flexible Teflon lip seals with Viton elastomers. The disperser shaft runs up to 695 rpm and is equipped with two 20” diameter sawtooth blades. The lower blade is stationary, while the upper blade is attached by means of an adjustable hub, enabling it to be raised or lowered to accommodate various batch volumes and ensure rapid wet-out of solid ingredients. The two-wing anchor is fabricated with a triangular cross-section, and is driven by a 40 HP motor up to 20 rpm that promotes bulk flow, continuous movement of the product towards the disperser blades, and efficient heat transfer across the jacketed surfaces. Both motors are explosion-proof, suitable for use in a Class I, Div 1, Groups F & G hazardous environment.


Related to this article

Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.